UNC93B1 drives IL-6/STAT3-dependent tumor–macrophage crosstalk and epithelial–mesenchymal transition in breast cancer
Background Lipid metabolic reprogramming is increasingly recognized as a driver of breast cancer progression; however, how lipid metabolism-associated risk states are translated into immune remodeling and epithelial–mesenchymal transition (EMT) remains unclear. This study aimed to identify a lipid metabolism-related re...